Insomnia and Sleeping Tablet Request

Clinical Scenario

James Mitchell, 34, a project manager, calls requesting sleeping tablets for insomnia that has worsened over 3-4 months since taking on a high-pressure work project. He lies awake until 2-3am with racing thoughts, uses his phone in bed, drinks 4-5 coffees daily including after dinner, and has tried OTC remedies without success. He has a history of mild sleep apnoea that improved with weight loss. He believes a short course of sleeping tablets will reset his sleep pattern.

What This Case Tests

Managing a medication request with evidence-based alternatives; conducting a comprehensive sleep assessment including screen use, caffeine, and sleep hygiene; explaining why hypnotics are not first-line for insomnia; recommending NICE-approved digital CBT-I (Sleepio); addressing work stress as a root cause without pathologising.

Common Mistakes Trainees Make

The three most common mistakes in this case are: prescribing a short course of zopiclone without addressing the underlying causes (which provides temporary relief but no lasting benefit), lecturing about sleep hygiene without first acknowledging the patient's distress and work pressure, and failing to offer a credible alternative that feels as concrete as a prescription. Trainees also commonly miss the sleep apnoea history — sedative medications are particularly risky in patients with a history of sleep-disordered breathing.

The Consultation Challenge

James is 34 years old, previously diagnosed with mild sleep apnoea that improved with weight loss, and now presents requesting sleeping tablets for difficulty sleeping. He has a high-pressure work project, has increased his caffeine intake to 4-5 cups daily including after dinner, uses his phone in bed, and has stopped going to the gym.

This is a "strong patient agenda" case similar to the diazepam-for-flying scenario. James wants a quick fix — a prescription — but the evidence-based approach is sleep hygiene optimisation and potentially CBT for insomnia (CBT-I). The examiner is testing whether you can redirect a specific medication request toward more effective treatment without alienating the patient.

The consultation has several layers. First, you need to take a thorough sleep history: what time does James go to bed, how long to fall asleep, how many awakenings, what time does he wake, and how does he feel during the day? Second, you must identify the modifiable contributing factors — late caffeine, screen use in bed, using the bedroom for work, reduced exercise, and cognitive arousal from work rumination.

The sleep apnoea history adds clinical complexity. Stress and lifestyle changes can trigger recurrence, so you should assess for symptoms (snoring, witnessed apnoeas, excessive daytime somnolence) and consider whether re-referral to sleep services is needed.

The management conversation should introduce CBT-I as the NICE-recommended first-line treatment, with Sleepio (the NHS-approved digital CBT-I programme) as an accessible option. If James pushes for medication, you can discuss short-course Z-drugs (zopiclone) for maximum 2-4 weeks as a bridge while behavioural changes take effect, but this should be a last resort, not the opening offer.

Time check: Spend the first 4 minutes on a structured sleep history and identifying contributing factors. By minute 6, address the sleep apnoea history and exclude recurrence. Use the remaining time for sleep hygiene advice, CBT-I recommendation, and shared decision-making about whether a short medication course is appropriate.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess the quality of your sleep history. They expect a structured approach: sleep onset latency, number of awakenings, early morning waking, sleep duration, daytime functioning, and sleep hygiene habits. Critically, you must identify the modifiable factors (caffeine, screens, exercise, stress) through targeted questioning rather than generic advice. The sleep apnoea history must be revisited — screening for recurrence demonstrates clinical thoroughness. Examiners also look for screening questions about mood and anxiety, as insomnia is frequently a symptom of an underlying mental health condition.

Clinical Management and Medical Complexity: The examiner expects you to know that CBT-I is first-line for chronic insomnia per NICE guidance, and that hypnotics should only be considered for short-term use (maximum 2-4 weeks) when insomnia is severe. You should demonstrate knowledge of the Sleepio app as an NHS-approved digital CBT-I tool. If discussing medication, show awareness of risks: dependence, rebound insomnia, next-day sedation, and the interaction between sedatives and sleep apnoea (respiratory depression risk). Personalised sleep hygiene advice — not a generic leaflet — demonstrates strong management.

Relating to Others: The challenge is declining the medication request without making James feel dismissed. Examiners assess whether you validate the impact of poor sleep on his work and wellbeing, explain your reasoning for recommending alternatives before medication, and use shared decision-making. A trainee who simply says "sleeping tablets are addictive" without exploring the patient's experience will score poorly.

Example Opening

Strong opening: "Hello James, I can see you're struggling with sleep. Before we talk about treatment options, I'd really like to understand what's happening with your sleep — can you walk me through a typical night for you?"

This opening signals that you are taking the problem seriously and gathering information before making decisions, which reassures the patient that they will be heard.

When redirecting from medication: "I hear you — when you're exhausted and under pressure at work, you want something that works tonight. I get that. But here's the thing: sleeping tablets actually make sleep quality worse over time, and there are approaches that fix the problem rather than mask it. Can I talk you through what the evidence says works best?"

Avoid: "We don't really like prescribing sleeping tablets these days." (Vague, impersonal, and does not explain why).

How This Appears in the SCA

Insomnia is a common SCA medication request scenario. The examiner assesses whether you can decline sleeping tablets while offering a credible, evidence-based alternative that the patient finds acceptable. This tests your negotiation skills under the strong patient agenda consultation type.

Key Statistic

CBT-I is effective in 70-80% of insomnia cases and produces sustained improvements, while hypnotic medications show reduced effectiveness after 2-4 weeks of use and carry significant dependency risk.

Relevant Guidelines

• NICE NG215: Medicines associated with dependence or withdrawal symptoms — recommends non-pharmacological approaches first-line for insomnia
• NICE endorsement of Sleepio (digital CBT-I) as NHS-approved treatment.

Frequently Asked Questions

Should I ever prescribe sleeping tablets in the SCA?

NICE recommends hypnotics only when insomnia is severe and debilitating, and only for short-term use (maximum 2-4 weeks). In the SCA context, the examiner wants to see that you offer CBT-I and sleep hygiene first. If you do discuss medication, demonstrate awareness of dependence risk, rebound insomnia, and that zopiclone or zolpidem should be prescribed at the lowest effective dose for the shortest possible duration. Prescribing without exploring alternatives first will score poorly.

What is CBT-I and why is it first-line for insomnia?

Cognitive Behavioural Therapy for Insomnia (CBT-I) is a structured programme that addresses the thoughts and behaviours maintaining insomnia. It includes sleep restriction, stimulus control, cognitive restructuring, and relaxation training. NICE recommends it as first-line because it produces sustained improvement without medication side effects or dependence. The Sleepio app is an NHS-approved digital CBT-I programme that patients can access immediately.

How do I give personalised sleep hygiene advice rather than generic tips?

Tie your advice directly to the factors you have identified in the history. Instead of "avoid screens before bed," say "you mentioned checking work emails in bed — that is training your brain to associate the bedroom with stress." Instead of "reduce caffeine," say "that post-dinner coffee at 8pm is still active in your system when you try to sleep at 11pm." Personalised advice demonstrates that you have listened and is much more likely to score well than handing out a leaflet.

What is the link between sleep apnoea and insomnia management?

This is a clinical complexity that examiners value. Sedative medications (benzodiazepines and Z-drugs) can worsen sleep apnoea by depressing respiratory drive. If the patient has a history of sleep apnoea — even if previously resolved — you must assess for recurrence before considering any sedating medication. This demonstrates patient safety awareness and clinical thoroughness.

How does work stress relate to insomnia in the SCA context?

The SCA tests holistic assessment. Work stress is both a cause and consequence of insomnia, creating a vicious cycle. Examiners look for whether you explore the work situation (without becoming a counsellor), assess for adjustment disorder or anxiety, and consider practical interventions like discussing the situation with occupational health or the patient's employer. Addressing only the sleep without acknowledging the underlying stressor shows incomplete assessment.